Utidelone Plus Bevacizumab for Advanced Breast Cancer With Brain Metastases
Clinical trial NCT05357417 · UNKNOWN
Trial details
- NCT number
- NCT05357417
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-29
- Primary completion
- 2024-05-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.